FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C 702 MODULE

MDR report key: 19059828 · Received April 8, 2024

Report

Report Number
1823260-2024-01065
Event Type
Malfunction
Date Received
April 8, 2024
Date of Event
March 18, 2024
Report Date
April 8, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PO
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE REAGENT LOT NUMBER IS 760784. THE EXPIRATION DATE WAS NOT PROVIDED. THE INVESTIGATION EXCLUDED REAGENT ISSUES AS NO FURTHER CASES WERE REPORTED AND A CORRECT RERUN WAS PERFORMED WITH THE SAME REAGENT. THE FIELD SERVICE ENGINEER (FSE) INSPECTED THE MODULE, CHANGED THE PIPETTOR ASSEMBLIES, AND PERFORMED READJUSTMENTS. HE CONFIRMED THAT THE ASSAY AND THE MODULE WERE AGAIN PERFORMING ACCORDING TO SPECIFICATIONS. THE INVESTIGATION DETERMINED THE EVENT WAS DUE TO A COMPONENT MALFUNCTION. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Description of Event or Problem · 0

THE INITIAL REPORTER RECEIVED QUESTIONABLE FERR4 (TINA-QUANT FERRITIN GEN.4) RESULTS FROM AN UNSPECIFIED NUMBER OF PATIENT SAMPLES TESTED ON THE COBAS 8000 C702 MODULE. THE REPORTER WAS ABLE TO PROVIDE ONE PATIENT SAMPLE WITH DISCREPANT RESULTS: THE INITIAL RESULT FROM THE C 702 MODULE WAS 0 NG/ML. THE INITIAL RESULT IN THE COBAS INFINITY WAS <5 U/L. THE REPEAT RESULT FROM THE C 702 MODULE WAS 45 NG/ML. THE REPEAT RESULT IN THE COBAS INFINITY WAS 45 U/L.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
121681 COBAS 8000 C 702 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 84 YR Male